FIRST TRUST US EQUITY OPPORTUNITIES ETF
112.90
14-March-25 16:30:01
15 minutes delayed
Funds
+4.41
+4.06%
Today's range
111.18 - 113.21
ISIN
N/A
Source
ETF NYSE
-
Pharming Group's (PHAR) Buy Rating Reaffirmed at HC Wainwright
15 Mar 2025 08:16:17 By Buzz FX
-
MYR Group (NASDAQ:MYRG) Rating Increased to Overweight at KeyCorp
15 Mar 2025 08:16:17 By Buzz FX
-
Sutro Biopharma (NASDAQ:STRO) Downgraded to Market Perform Rating by Citizens Jmp
15 Mar 2025 08:16:17 By Buzz FX
-
Nektar Therapeutics (NASDAQ:NKTR) Stock Rating Upgraded by Oppenheimer
15 Mar 2025 08:16:17 By Buzz FX
-
Peloton Interactive (NASDAQ:PTON) Stock Rating Upgraded by Canaccord Genuity Group
15 Mar 2025 08:16:17 By Buzz FX
-
Wedbush Downgrades Sutro Biopharma (NASDAQ:STRO) to Neutral
15 Mar 2025 08:16:17 By Buzz FX
-
Tourmaline Bio (NASDAQ:TRML) Stock Price Expected to Rise, HC Wainwright Analyst Says
15 Mar 2025 08:16:17 By Buzz FX
-
Nuvalent (NASDAQ:NUVL) Upgraded by UBS Group to Buy Rating
15 Mar 2025 08:16:17 By Buzz FX
-
1st Source Co. (NASDAQ:SRCE) Short Interest Down 42.3% in February
15 Mar 2025 08:16:17 By Buzz FX
-
Semtech's (SMTC) "Buy" Rating Reaffirmed at Needham & Company LLC
15 Mar 2025 08:16:17 By Buzz FX
-
Sana Biotechnology (NASDAQ:SANA) Earns Buy Rating from Analysts at Jefferies Financial Group
15 Mar 2025 08:16:17 By Buzz FX
-
Semtech (NASDAQ:SMTC) Price Target Cut to $68.00 by Analysts at Benchmark
15 Mar 2025 08:16:17 By Buzz FX
-
Blink Charging's (BLNK) "Hold" Rating Reaffirmed at Needham & Company LLC
15 Mar 2025 08:16:17 By Buzz FX
-
Piper Sandler Issues Pessimistic Forecast for Manhattan Associates (NASDAQ:MANH) Stock Price
15 Mar 2025 08:16:17 By Buzz FX
-
DocuSign (NASDAQ:DOCU) Earns Hold Rating from Needham & Company LLC
15 Mar 2025 08:16:17 By Buzz FX
-
89bio (NASDAQ:ETNB) Coverage Initiated by Analysts at The Goldman Sachs Group
15 Mar 2025 08:16:17 By Buzz FX
-
G-III Apparel Group (NASDAQ:GIII) Price Target Cut to $30.00 by Analysts at Telsey Advisory Group
15 Mar 2025 08:16:17 By Buzz FX
-
Regulus Therapeutics' (RGLS) "Buy" Rating Reaffirmed at HC Wainwright
15 Mar 2025 08:16:17 By Buzz FX
-
Sutro Biopharma (NASDAQ:STRO) Lowered to "Underperform" Rating by Bank of America
15 Mar 2025 08:16:17 By Buzz FX
-
Protara Therapeutics (NASDAQ:TARA) Coverage Initiated by Analysts at Cantor Fitzgerald
15 Mar 2025 08:16:17 By Buzz FX